TRAIL regulates T cell activation and suppresses inflammation in autoimmune diseases
Journal
Cellular and Molecular Immunology
Journal Volume
17
Journal Issue
12
Pages
1281-1283
Date Issued
2020
Author(s)
Chyuan I.-T.
SDGs
Other Subjects
caspase inhibitor; CD28 antigen; CD3 antigen; Fas ligand; tumor necrosis factor related apoptosis inducing ligand; tumor necrosis factor related apoptosis inducing ligand receptor; unclassified drug; z vad fmk; lymphocyte antigen receptor; tumor necrosis factor related apoptosis inducing ligand; adoptive transfer; allergic encephalomyelitis; apoptosis; arthritis; autoimmune arthritis; autoimmune colitis; autoimmune disease; colitis; collagen antibody-induced arthritis; cytokine production; disease severity; enzyme activation; enzyme inhibition; experimental autoimmune encephalomyelitis; fibroblast; homeostasis; human; immune response; immunoregulation; in vivo study; Letter; lipid raft; lymphocyte proliferation; lymphocytic infiltration; macrophage; nonhuman; pathogenesis; protein binding; protein function; protein phosphorylation; protein protein interaction; regulatory T lymphocyte; signal transduction; synovial fibroblast; T lymphocyte activation; Th17 cell; animal; autoimmune disease; C57BL mouse; immunology; inflammation; lymphocyte activation; metabolism; pathology; T lymphocyte; Animals; Apoptosis; Autoimmune Diseases; Inflammation; Lymphocyte Activation; Mice, Inbred C57BL; Receptors, Antigen, T-Cell; Signal Transduction; T-Lymphocytes; TNF-Related Apoptosis-Inducing Ligand
Publisher
Springer Nature
Type
letter